INC Research Holdings, Inc., a global Phase I to IV contract research organization (CRO), has launched the industry’s first Site Advocacy Group (SAG) devoted to the scientific and operational aspects of clinical research. The SAG initially will focus on central nervous system (CNS) protocols—recognized as among the more complex therapeutic areas in clinical research—targeting psychiatry studies including, but not limited to, those in schizophrenia, attention-deficit/hyperactivity disorder (ADHD)...